Literature DB >> 9034196

ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion.

P J Pussinen1, M Jauhiainen, C Ehnholm.   

Abstract

Pig plasma phospholipid transfer protein (PLTP) facilitates interconversion of both human HDL3 and pig HDL into HDL subpopulations of large and small particles. We recently suggested that there are two essential parts in the conversion mechanism, i.e., the release of apoA-I and phospholipids and the fusion of apoA-I-depleted unstable particles. Based on their mass composition and electrophoretic mobility in agarose gel, the released apoA-I-containing particles are similar to previously described pre beta-HDL particles known as primary acceptors of peripheral cholesterol. The aim of this study was to determine whether the apolipoprotein composition of HDL regulates the PLTP-mediated conversion process. Pig HDL was incubated with increasing amounts of human apoA-II which incorporates into pig HDL with a concomitant release of apoA-I and some phospholipids. These hybrid pig HDL particles formed were isolated by a combination of ultracentrifugation at density 1.21 g/ml and gel filtration. The apoA-II/apoA-I molar ratios in the hybrid HDL particles ranged from 0.2 to 7.6 mol/mol. In the maximally modified HDL apoA-I was totally substituted by apoA-II. These particles were incubated in the presence of purified PLTP and the conversion products were isolated and characterized. Both the formation of large particles and the release of apoA-I were inhibited by increasing concentrations of apoA-II in the HDL particle. The hybrid HDL particles behaved similarly as native pig HDL as acceptors of phospholipid from PC-vesicles in the PLTP-assay. This study suggests that the apoA-II/apoA-I molar ratio in the HDL particle regulates PLTP-mediated HDL interconversion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034196

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

Review 1.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

2.  Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.

Authors:  Su Duy Nguyen; Katariina Öörni; Miriam Lee-Rueckert; Tero Pihlajamaa; Jari Metso; Matti Jauhiainen; Petri T Kovanen
Journal:  J Lipid Res       Date:  2012-08-01       Impact factor: 5.922

Review 3.  The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations.

Authors:  L Tian; M Fu
Journal:  J Endocrinol Invest       Date:  2011-06       Impact factor: 4.256

4.  Kinetic stabilization and fusion of apolipoprotein A-2:DMPC disks: comparison with apoA-1 and apoC-1.

Authors:  Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

5.  High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli.

Authors:  Loren E Smith; Jun Yang; Leah Goodman; Xinqi Huang; Rong Huang; James Dressman; Jamie Morris; R A Gangani D Silva; W Sean Davidson; Giorgio Cavigiolio
Journal:  J Lipid Res       Date:  2012-05-25       Impact factor: 5.922

6.  Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

7.  Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

Authors:  Marian C Cheung; Gertrud Wolfbauer; Hiroshi Deguchi; José A Fernández; John H Griffin; John J Albers
Journal:  Biochim Biophys Acta       Date:  2008-12-30

8.  Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.

Authors:  Margaret E Brousseau; John S Millar; Margaret R Diffenderfer; Chorthip Nartsupha; Bela F Asztalos; Megan L Wolfe; James P Mancuso; Andres G Digenio; Daniel J Rader; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2009-02-03       Impact factor: 5.922

9.  High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy.

Authors:  Laxman Yetukuri; Ilkka Huopaniemi; Artturi Koivuniemi; Marianna Maranghi; Anne Hiukka; Heli Nygren; Samuel Kaski; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Orešič
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

10.  Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.

Authors:  Timo Paavola; Sanna Kuusisto; Matti Jauhiainen; Sakari Kakko; Tiia Kangas-Kontio; Jari Metso; Pasi Soininen; Mika Ala-Korpela; Risto Bloigu; Minna L Hannuksela; Markku J Savolainen; Tuire Salonurmi
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.